AJOVY, a migraine drug, significantly reduced headaches in kids and teens, and is now FDA-approved for those 6–17.

The FDA released AI drug development guidelines, with one AI-designed drug now in clinical trials.

Cell Source raised $1.5M in convertible notes, with warrants, to advance therapies and prepare for a Nasdaq uplist.

A new treatment eases symptoms of rare genetic disorders affecting amino acid breakdown, improving patients' lives, a January 12, 2026, report says.

ADHD symptoms in women often worsen during menopause, menstruation, and postpartum due to falling estrogen levels, a new study of 600 women finds.

A British woman must pay £200 monthly for life after ending her participation in a drug program tied to Mounjaro.

GCCL and OPIS partner to boost global clinical trial efficiency and access.

Careboo, a Chinese medical device maker, expands globally with internationally certified respiratory and sleep therapy devices.

A new immunotherapy shows promise in treating 'Brain on Fire,' a rare autoimmune disorder, according to recent clinical trial results.

St. Luke’s in Cedar Rapids becomes first local hospital to use cryobiopsy for precise, safer lung cancer diagnosis.